Taylor Andrew Lawrence

Taylor Andrew Lawrence, Chief Financial Officer, has filed 4 insider trading reports covering 1 company. Total disclosed trading volume is $85.2K. The predominance of buying activity ($5.1K in purchases vs. $0 in sales) may reflect this insider's confidence in the underlying companies. The largest single filing involves Orchestra BioMed Holdings, Inc. (OBIO). All transactions sourced from SEC Form 4 filings.